Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

‘Killer’ cells used to combat rare cancer

10.09.2002


Scientists from the University of Edinburgh are using immune cells harvested from blood donors to help fight an unusual cancer which can affect transplant patients. And their findings, published recently in The Lancet show that the therapy has proved effective in a number of cases. The treatment proved successful last year in saving the life of a four-year-old boy from Birmingham, who developed the cancer— post-transplant lympho-proliferative disease— following a liver and bowel transplant.



The technique, which involves boosting the patient’s own immune system to fight cancer without affecting the transplanted organ, can also be adapted to treat other virus infections, or AIDS patients who have developed lymphomas.

Clinical research scientist Dr Tanzina Haque explained: “The Epstein-Barr virus (EBV) is a common virus best known for causing glandular fever, and is carried by about 90% of the population, without a problem. When a patient receives an organ transplant, he or she is given immuno-suppressive drugs to stop the body rejecting the organ, but this also lowers their immunity to infections by removing the body’s ’killer’ cells, the cytotoxic T-lymphocytes. If a transplant patient’s immunity is compromised, EBV can infect cells called B-lymphocytes, causing them to grow in an uncontrolled way and become malignant. The resulting cancer can be fatal in up to 70% of cases.”


Dr Haque said that to reduce doses of immuno-suppressive drugs could cause organ transplant rejection, so the Edinburgh team, headed by Professor Dorothy Crawford and backed by funding from Cancer Research UK, devised a method of removing ‘killer’ cells from screened blood donations and tissue-type matching them to transplant patients. Should any patients develop lymphoma, they can be infused with matched cells from the bank containing more than 100 blood donations.

The technique, known as Cytotoxic T-Lymphocyte (CTL) Therapy, has shown to have no adverse side-effects for patients. Results published in The Lancet show of eight patients in the trial who were suitable for treatment, two died, five made a complete recovery, two did not respond and one showed a partial response. Two further patients died before their tumour response could be evaluated.

Dr Haque said this UK-wide multicentre clinical trial could not have been possible without the collaboration of the Scottish National Blood Transfusion Service, different transplant centers, and the many blood donors who helped by allowing their blood to be used for generating the T-cells.

Linda Menzies | alfa
Further information:
http://www.ed.ac.uk/news/

More articles from Health and Medicine:

nachricht Building blocks for new medications: the University of Graz is seeking a technology partner
19.03.2019 | Karl-Franzens-Universität Graz

nachricht Scientists find new approach that shows promise for treating cystic fibrosis
14.03.2019 | NIH/National Heart, Lung and Blood Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Stellar cartography

The Potsdam Echelle Polarimetric and Spectroscopic Instrument (PEPSI) at the Large Binocular Telescope (LBT) in Arizona released its first image of the surface magnetic field of another star. In a paper in the European journal Astronomy & Astrophysics, the PEPSI team presents a Zeeman- Doppler-Image of the surface of the magnetically active star II Pegasi.

A special technique allows astronomers to resolve the surfaces of faraway stars. Those are otherwise only seen as point sources, even in the largest telescopes...

Im Focus: Heading towards a tsunami of light

Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have proposed a way to create a completely new source of radiation. Ultra-intense light pulses consist of the motion of a single wave and can be described as a tsunami of light. The strong wave can be used to study interactions between matter and light in a unique way. Their research is now published in the scientific journal Physical Review Letters.

"This source of radiation lets us look at reality through a new angle - it is like twisting a mirror and discovering something completely different," says...

Im Focus: Revealing the secret of the vacuum for the first time

New research group at the University of Jena combines theory and experiment to demonstrate for the first time certain physical processes in a quantum vacuum

For most people, a vacuum is an empty space. Quantum physics, on the other hand, assumes that even in this lowest-energy state, particles and antiparticles...

Im Focus: Sussex scientists one step closer to a clock that could replace GPS and Galileo

Physicists in the EPic Lab at University of Sussex make crucial development in global race to develop a portable atomic clock

Scientists in the Emergent Photonics Lab (EPic Lab) at the University of Sussex have made a breakthrough to a crucial element of an atomic clock - devices...

Im Focus: Sensing shakes

A new way to sense earthquakes could help improve early warning systems

Every year earthquakes worldwide claim hundreds or even thousands of lives. Forewarning allows people to head for safety and a matter of seconds could spell...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Modelica Conference with 330 visitors from 21 countries at OTH Regensburg

11.03.2019 | Event News

Selection Completed: 580 Young Scientists from 88 Countries at the Lindau Nobel Laureate Meeting

01.03.2019 | Event News

LightMAT 2019 – 3rd International Conference on Light Materials – Science and Technology

28.02.2019 | Event News

 
Latest News

Levitating objects with light

19.03.2019 | Physics and Astronomy

New technique for in-cell distance determination

19.03.2019 | Life Sciences

Stellar cartography

19.03.2019 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>